Research and Markets: Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics (Updated Edition)

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9rc77t/royalty_financing) has announced the addition of the "Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics (7th Edition)" report to their offering.

The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

The Royalty Financing Terms and Agreements report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies.

The report provides a detailed understand and analysis of how and why companies enter royalty financing partnering deals.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

Report scope

  • Trends in royalty financing dealmaking in the biopharma industry since 2007
  • Analysis of royalty financing deal structure
  • Case studies of real-life royalty financing deals
  • Comprehensive listing of royalty financing deals since 2007
  • Access to royalty financing contract documents
  • The leading royalty financing deals by value since 2007
  • Most active royalty financing dealmakers since 2007
  • The leading royalty financing partnering resources

In Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics, available contracts are listed by:

  • Company A-Z
  • Headline value
  • Therapeutic area

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in royalty financing dealmaking

Chapter 3 - Overview of royalty financing structure

Chapter 4 - Leading royalty financing deals

Chapter 5 - Royalty financing contract documents 2007-2014

Chapter 6 - Royalty financing agreement directory 2007-2014

For more information visit http://www.researchandmarkets.com/research/9rc77t/royalty_financing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices